One possible mechanism through which ALK mutations may render neuroblastoma more aggressive is through increased MYCN activity resulting from PI3K-directed activation of ERK5 transcription levels or inhibiting GSK3ß-mediated repression of MYCN protein degradation11,12. Here, MYCN is linked to neuroblastoma.